FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bruce Ivins

Research Profile

Living Beings

Disorders

Anthrax

Chemicals & Drugs

Anatomy

Spores, Bacterial

Procedures

Co-author Network

Publications

TOP 3
Richard T Okinaka; Talima Pearson; Erin P Price; James M Schupp; Spenser R Wolken; Gary Xie; Chris Munk; Stephen Beckstrom-Sternberg; Jean Challacombe; Wai Kwan Chung; Arthur Friedlander; Jeffrey M Gruendike; Karen K Hill; Bruce E Ivins; Paul Keim
An attenuated strain of Bacillus anthracis (CDC 684) has a large chromosomal inversion and altered growth kinetics.
Henry S Heine; J Bassett; Lynda Miller; A Bassett; Bruce E Ivins; D Lehoux; F F Arhin; T R Parr; Greg Moeck
Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax.
John Hewetson; Stephen F Little; Bruce E Ivins; Wendy M Johnson; Phillip R Pittman; J Edward Brown; Sarah L Norris; Carl J Nielsen
An in vivo passive protection assay for the evaluation of immunity in AVA-vaccinated individuals.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bruce Ivins (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Richard T Okinaka; Talima Pearson; Erin P Price; James M Schupp; Spenser R Wolken; Gary Xie; Chris Munk; Stephen Beckstrom-Sternberg; Jean Challacombe; Wai Kwan Chung; Arthur Friedlander; Jeffrey M Gruendike; Karen K Hill; Bruce E Ivins; Paul Keim
An attenuated strain of Bacillus anthracis (CDC 684) has a large chromosomal inversion and altered growth kinetics.
BMC genomics 2011;12():477.
2008: Henry S Heine; J Bassett; Lynda Miller; A Bassett; Bruce E Ivins; D Lehoux; F F Arhin; T R Parr; Greg Moeck
Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax.
Antimicrobial agents and chemotherapy 2008;52(9):3350-7.
2008: John Hewetson; Stephen F Little; Bruce E Ivins; Wendy M Johnson; Phillip R Pittman; J Edward Brown; Sarah L Norris; Carl J Nielsen
An in vivo passive protection assay for the evaluation of immunity in AVA-vaccinated individuals.
Vaccine 2008;26(33):4262-6.
2007: Stephen F Little; Bruce E Ivins; Wendy Webster; Sarah L Norris; Gerard P Andrews
Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine.
Vaccine 2007;25(15):2771-7.
2007: Henry S Heine; Jennifer Bassett; Lynda Miller; Justin M Hartings; Bruce E Ivins; M Louise M Pitt; David Fritz; Sarah L Norris; W Russell Byrne
Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model.
Antimicrobial agents and chemotherapy 2007;51(4):1373-9.
2006: Dennis M Klinman; Hang Xie; Bruce E Ivins
CpG oligonucleotides improve the protective immune response induced by the licensed anthrax vaccine.
Annals of the New York Academy of Sciences 2006;1082():137-50.
2006: Nicholas J Vietri; Bret K Purcell; James V Lawler; Elizabeth K Leffel; Pedro Rico; Christopher S Gamble; Nancy A Twenhafel; Bruce E Ivins; Henry S Heine; Ryan Sheeler; Mary E Wright; Arthur M Friedlander
Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(20):7813-6.
2006: Wilson J Ribot; Bradford S Powell; Bruce E Ivins; Stephen F Little; W M Johnson; Timothy A Hoover; Sarah L Norris; Jeffrey J Adamovicz; Arthur M Friedlander; Gerard P Andrews
Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits.
Vaccine 2006;24(17):3469-76.
2006: Stephen F Little; Bruce E Ivins; Wendy Webster; Patricia F Fellows; M Louise M Pitt; Sarah L Norris; Gerard P Andrews
Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine.
Vaccine 2006;24(14):2530-6.
2004: Dennis M Klinman; Hang Xie; Stephen F Little; Debra Currie; Bruce E Ivins
CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques.
Vaccine 2004;22(21-22):2881-6.
2004: Stephen F Little; Wendy Webster; Bruce E Ivins; Patricia F Fellows; Sarah L Norris; Gerard P Andrews
Development of an in vitro-based potency assay for anthrax vaccine.
Vaccine 2004;22(21-22):2843-52.
2004: Stephen F Little; Bruce E Ivins; Patricia F Fellows; M Louise M Pitt; Sarah L Norris; Gerard P Andrews
Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine.
Vaccine 2004;22(3-4):422-30.
2002: Patricia F Fellows; M K Linscott; Stephen F Little; Paul Gibbs; Bruce E Ivins
Anthrax vaccine efficacy in golden Syrian hamsters.
Vaccine 2002;20(9-10):1421-4.
2002: Arthur M Friedlander; Susan L Welkos; Bruce E Ivins
Anthrax vaccines.
Current topics in microbiology and immunology 2002;271():33-60.
2001: M Louise M Pitt; Stephen F Little; Bruce E Ivins; Patricia F Fellows; J Barth; John Hewetson; Paul Gibbs; M Dertzbaugh; Arthur M Friedlander
In vitro correlate of immunity in a rabbit model of inhalational anthrax.
Vaccine 2001;19(32):4768-73.
2001: Patricia F Fellows; M K Linscott; Bruce E Ivins; M Louise M Pitt; Cynthia A Rossi; Paul H Gibbs; Arthur M Friedlander
Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin.
Vaccine 2001;19(23-24):3241-7.
1999: A S Hail; Cynthia A Rossi; George V Ludwig; Bruce E Ivins; RF Tammariello; Erik A Henchal
Comparison of noninvasive sampling sites for early detection of Bacillus anthracis spores from rhesus monkeys after aerosol exposure.
Military medicine 1999;164(12):833-7.
1999: Stephen F Little; Bruce E Ivins
Molecular pathogenesis of Bacillus anthracis infection.
Microbes and infection / Institut Pasteur 1999;1(2):131-9.
1998: G M Zaucha; L M Pitt; J Estep; Bruce E Ivins; Arthur M Friedlander
The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation.
Archives of pathology & laboratory medicine 1998;122(11):982-92.
1998: Bruce E Ivins; M Louise M Pitt; Patricia F Fellows; J W Farchaus; GE Benner; David M Waag; Stephen F Little; GW Anderson; Paul H Gibbs; Arthur M Friedlander
Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques.
Vaccine 1998;16(11-12):1141-8.
1997: Stephen F Little; Bruce E Ivins; Patricia F Fellows; Arthur M Friedlander
Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs.
Infection and immunity 1997;65(12):5171-5.
1995: Bruce E Ivins; Patricia F Fellows; L Pitt; J Estep; J Farchaus; A Friedlander; P Gibbs
Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs.
Vaccine 1995;13(18):1779-84.
1994: Bruce E Ivins; Patricia F Fellows; G O Nelson
Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs.
Vaccine 1994;12(10):872-4.
1993: Arthur M Friedlander; Susan L Welkos; M Louise M Pitt; J W Ezzell; P L Worsham; K J Rose; Bruce E Ivins; J R Lowe; G B Howe; P Mikesell
Postexposure prophylaxis against experimental inhalation anthrax.
The Journal of infectious diseases 1993;167(5):1239-43.
1992: Bruce E Ivins; Susan L Welkos; Stephen F Little; M H Crumrine; G O Nelson
Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants.
Infection and immunity 1992;60(2):662-8.
1991: L C Iacono-Connors; Susan L Welkos; Bruce E Ivins; J M Dalrymple
Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals.
Infection and immunity 1991;59(6):1961-5.
1990: Bruce E Ivins; Susan L Welkos; G B Knudson; Stephen F Little
Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen.
Infection and immunity 1990;58(2):303-8.
1989: Bruce E Ivins; J D Ristroph; G O Nelson
Influence of body weight on response of Fischer 344 rats to anthrax lethal toxin.
Applied and environmental microbiology 1989;55(8):2098-100.
1988: Bruce E Ivins; Susan L Welkos
Recent advances in the development of an improved, human anthrax vaccine.
European journal of epidemiology 1988;4(1):12-9.
1988: Bruce E Ivins; Susan L Welkos; G B Knudson; D J Leblanc
Transposon Tn916 mutagenesis in Bacillus anthracis.
Infection and immunity 1988;56(1):176-81.
1986: Bruce E Ivins; Susan L Welkos
Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis.
Infection and immunity 1986;54(2):537-42.
1986: Bruce E Ivins; J W Ezzell; J Jemski; K W Hedlund; J D Ristroph; Stephen H Leppla
Immunization studies with attenuated strains of Bacillus anthracis.
Infection and immunity 1986;52(2):454-8.
1984: J W Ezzell; Bruce E Ivins; Stephen H Leppla
Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin.
Infection and immunity 1984;45(3):761-7.
1983: J D Ristroph; Bruce E Ivins
Elaboration of Bacillus anthracis antigens in a new, defined culture medium.
Infection and immunity 1983;39(1):483-6.
1983: P Mikesell; Bruce E Ivins; J D Ristroph; T M Dreier
Evidence for plasmid-mediated toxin production in Bacillus anthracis.
Infection and immunity 1983;39(1):371-6.